Cite
MLA Citation
James Berenson et al.. “A phase 2 safety study of accelerated elotuzumab infusion, over less than 1 h, in combination with lenalidomide and dexamethasone, in patients with multiple myeloma.” American journal of hematology, vol. 92, no. 5, n.d., pp. 460–466. http://access.bl.uk/ark:/81055/vdc_100045397927.0x000041